Repligen Corp (RGEN)
142.58
+0.82
(+0.58%)
USD |
NASDAQ |
Nov 22, 16:00
142.62
+0.04
(+0.03%)
After-Hours: 20:00
Repligen Cash from Financing (Quarterly): -69.60M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -69.60M |
| June 30, 2024 | -5.773M |
| March 31, 2024 | -8.974M |
| December 31, 2023 | 268.13M |
| September 30, 2023 | -0.778M |
| June 30, 2023 | -8.825M |
| March 31, 2023 | -9.563M |
| December 31, 2022 | -0.274M |
| September 30, 2022 | 1.251M |
| June 30, 2022 | -2.293M |
| March 31, 2022 | -12.02M |
| December 31, 2021 | 0.231M |
| September 30, 2021 | -0.122M |
| June 30, 2021 | 0.345M |
| March 31, 2021 | 0.507M |
| December 31, 2020 | 298.84M |
| September 30, 2020 | 1.676M |
| June 30, 2020 | 3.813M |
| March 31, 2020 | 1.589M |
| December 31, 2019 | -0.18M |
| September 30, 2019 | 294.88M |
| June 30, 2019 | 190.13M |
| March 31, 2019 | 0.044M |
| December 31, 2018 | 1.044M |
| September 30, 2018 | 0.884M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.146M |
| March 31, 2018 | 0.333M |
| December 31, 2017 | 0.303M |
| September 30, 2017 | 129.81M |
| June 30, 2017 | 0.158M |
| March 31, 2017 | -0.33M |
| December 31, 2016 | -0.089M |
| September 30, 2016 | 0.419M |
| June 30, 2016 | 111.46M |
| March 31, 2016 | 0.323M |
| December 31, 2015 | -0.061M |
| September 30, 2015 | 0.241M |
| June 30, 2015 | 0.284M |
| March 31, 2015 | 0.303M |
| December 31, 2014 | 0.798M |
| September 30, 2014 | -0.4559M |
| June 30, 2014 | 0.8402M |
| March 31, 2014 | 0.4977M |
| December 31, 2013 | 0.6628M |
| September 30, 2013 | -0.1754M |
| June 30, 2013 | 1.078M |
| March 31, 2013 | 0.9567M |
| December 31, 2012 | 0.2724M |
| September 30, 2012 | 0.7517M |
| June 30, 2012 | 0.0214M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-69.60M
Minimum
Sep 2024
298.84M
Maximum
Dec 2020
22.90M
Average
-0.151M
Median
Cash from Financing (Quarterly) Benchmarks
| West Pharmaceutical Services Inc | -64.40M |
| QuidelOrtho Corp | -26.30M |
| Perspective Therapeutics Inc | 0.628M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 49.32M |
| Cash from Investing (Quarterly) | -5.859M |
| Free Cash Flow | 131.26M |
| Free Cash Flow Per Share (Quarterly) | 0.7531 |
| Free Cash Flow to Equity (Quarterly) | 107.78M |
| Free Cash Flow to Firm (Quarterly) | 45.34M |
| Free Cash Flow Yield | 1.64% |